Evidence map›Paper›PMID 26222144›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Toll-Like Receptor 4 Engagement Mediates Prolyl Endopeptidase Release from Airway Epithelia via Exosomes.

Tomasz Szul, Preston E Bratcher, Kyle B Fraser, Michele Kong, Rabindra Tirouvanziam, Sarah Ingersoll, Elizabeth Sztul, Sunil Rangarajan, J Edwin Blalock, Xin Xu and 1 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exosome-encapsulated lncRNA HOTAIRM1 contributes to PMScience China. Life sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Role of extracellular vesicles in severe pneumonia and sepsis.Expert opinion on biological therapy · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tomasz Szul1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
Preston E Bratcher1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
Kyle B FraserDepartments of 3 Neurology and.
Michele Kong4 Pediatrics.
Rabindra Tirouvanziam2 Program in Protease and Matrix Biology.
Sarah Ingersoll6 Department of Pediatrics and Emory+Children's Center for Cystic Fibrosis and Airways Disease Research, Emory University, Atlanta, Georgia; and.
Elizabeth Sztul7 Department of Cell, Developmental and Integrative Biology, and.
Sunil Rangarajan1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
J Edwin Blalock1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
Xin Xu1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
Amit Gaggar1 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine.
Pulmonary and Allergy Associates · USCystic Fibrosis Foundation · USEmory University · USIntegrative Medicine Institute · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
A Novel Proteolytic System of Pulmonary InflammationR01HL102371 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2021
$3.3M
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation inR01HL090999 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2007 to 2010
$1.5M
PGP, A Possible Biomarker for COPD Exacerbations and or ProgressionR01HL114439 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2012 to 2015
$1.5M
Therapeutics for Chronic Lung Diseases: Antagonists of PGP, Chemokines and CXCRR01HL087824 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2009 to 2010
$823k
Matrix Metalloproteinase Driven Lung Inflammation in RSV diseaseK08HL119359 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KONG, MICHELE · 2014 to 2018
$715k
MODELING OF CARDIAC ARRHYTHMIA GENERATORSF33HL007783 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI GESELOWITZ, DAVID B. · 1988 to 1988
–
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPDI01BX001756 · VA · BIRMINGHAM VA MEDICAL CENTER · PI GAGGAR, AMIT · 2015 to 2018
–
BLRD VA I01 BX001756NHLBI NIH HHS 5T32HL007457NHLBI NIH HHS HL07783NHLBI NIH HHS HL087824NHLBI NIH HHS HL102371NHLBI NIH HHS K08 HL119359NHLBI NIH HHS R01 HL087824NHLBI NIH HHS R01 HL090999NHLBI NIH HHS R01 HL102371NHLBI NIH HHS R01 HL114439NHLBI NIH HHS T32 HL007457NIAMS NIH HHS P30 AR048311PHS HHS H L090999
6 · The paper itself

Abstract

Proteases are important regulators of pulmonary remodeling and airway inflammation. Recently, we have characterized the enzyme prolyl endopeptidase (PE), a serine peptidase, as a critical protease in the generation of the neutrophil chemoattractant tripeptide Pro-Gly-Pro (PGP) from collagen. However, PE has been characterized as a cytosolic enzyme, and the mechanism mediating PE release extracellularly remains unknown. We examined the role of exosomes derived from airway epithelia as a mechanism for PE release and the potential extracellular signals that regulate the release of these exosomes. We demonstrate a specific regulatory pathway of exosome release from airway epithelia and identify PE as novel exosome cargo. LPS stimulation of airway epithelial cells induces release of PE-containing exosomes, which is significantly attenuated by small interfering RNA depletion of Toll-like receptor 4 (TLR4). These differences were recapitulated upon intratracheal LPS administration in mice competent versus deficient for TLR4 signaling. Finally, sputum samples from subjects with cystic fibrosis colonized with Pseudomonas aeruginosa demonstrate elevated exosome content and increased PE levels. This TLR4-based mechanism highlights the first report of nonstochastic release of exosomes in the lung and couples TLR4 activation with matrikine generation. The increased quantity of these proteolytic exosomes in the airways of subjects with chronic lung disease highlights a new mechanism of injury and inflammation in the pathogenesis of pulmonary disorders.

Indexed as

AdultAnimalsBronchiCase-Control StudiesCell LineCystic FibrosisDose-Response Relationship, DrugEpithelial CellsExosomesFemaleHumansLipopolysaccharidesMaleMice, Inbred C3HMice, KnockoutMitochondrial ProteinsLipopolysaccharidesMitochondrial ProteinsPREPL protein, humanPREP protein, humanProlyl OligopeptidasesSerine EndopeptidasesTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4cystic fibrosisexosomeproteasepulmonaryToll-like receptor 4

Identifiers

PMID26222144
PMCPMC5455678
OpenAlexW1944935837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.